Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Temporal response of the human virome to immunosuppression and antiviral therapy.

De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, Okamoto J, Snyder TM, Cornfield DN, Nicolls MR, Weill D, Bernstein D, Valantine HA, Quake SR.

Cell. 2013 Nov 21;155(5):1178-87. doi: 10.1016/j.cell.2013.10.034.

2.

Microbiome: anelloviridae go viral.

Hofer U.

Nat Rev Microbiol. 2014 Jan;12(1):4-5. doi: 10.1038/nrmicro3192. No abstract available.

PMID:
24336177
4.

Everolimus-based immunosuppressive regimens in lung transplant recipients: impact on CMV infection.

Rittà M, Costa C, Solidoro P, Sidoti F, Libertucci D, Boffini M, Rinaldi M, Baldi S, Cavallo R.

Antiviral Res. 2015 Jan;113:19-26. doi: 10.1016/j.antiviral.2014.10.016. Epub 2014 Nov 7.

5.

Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation.

Gerbase MW, Dubois D, Rothmeier C, Spiliopoulos A, Wunderli W, Nicod LP.

Chest. 1999 Nov;116(5):1265-72.

PMID:
10559085
6.

Provision of laboratory services for heart and lung transplantation in Australia.

Schneider HG, Rutherford D, Kotsimbos T.

Clin Chim Acta. 2001 Nov;313(1-2):221-9.

PMID:
11694263
7.

Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.

Na R, Laaksonen MA, Grulich AE, Webster AC, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Clin Transplant. 2015 Nov;29(11):978-90. doi: 10.1111/ctr.12617. Epub 2015 Sep 24.

PMID:
26278925
8.

Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.

Costa C, Astegiano S, Terlizzi ME, Sidoti F, Curtoni A, Solidoro P, Baldi S, Bergallo M, Cavallo R.

Transplant Proc. 2011 May;43(4):1159-61. doi: 10.1016/j.transproceed.2011.03.024.

PMID:
21620077
9.

Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.

Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK.

Am J Transplant. 2004 Jan;4(1):108-15.

10.

[Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].

Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M.

Mikrobiyol Bul. 2016 Apr;50(2):224-35. Turkish.

11.

New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.

Wagner K, Webber SA, Kurland G, Boyle GJ, Miller SA, Cipriani L, Griffith BP, Fricker FJ.

J Heart Lung Transplant. 1997 Mar;16(3):275-82.

PMID:
9087870
12.

Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.

Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER.

J Heart Lung Transplant. 2008 Sep;27(9):990-4. doi: 10.1016/j.healun.2008.06.005.

PMID:
18765191
13.

Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.

Iwasenko JM, Scott GM, Naing Z, Glanville AR, Rawlinson WD.

Transpl Infect Dis. 2011 Apr;13(2):145-53. doi: 10.1111/j.1399-3062.2010.00584.x. Epub 2010 Nov 10.

PMID:
21070537
14.

Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients.

Young JC, Chehoud C, Bittinger K, Bailey A, Diamond JM, Cantu E, Haas AR, Abbas A, Frye L, Christie JD, Bushman FD, Collman RG.

Am J Transplant. 2015 Jan;15(1):200-9. doi: 10.1111/ajt.13031. Epub 2014 Nov 17.

15.

Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis.

Michaelides A, Liolios L, Glare EM, Spelman DW, Bailey MJ, Walters EH, Williams TJ, Snell GI, Kotsimbos TC.

Transplantation. 2001 Jul 15;72(1):141-7.

PMID:
11468549
16.

Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients.

Boyle GJ, Michaels MG, Webber SA, Knisely AS, Kurland G, Cipriani LA, Griffith BP, Fricker FJ.

J Pediatr. 1997 Aug;131(2):309-13.

PMID:
9290623
17.

Prevention and treatment of cytomegalovirus infection in organ transplant recipients.

Kusne S, Shapiro R, Fung J.

Transpl Infect Dis. 1999 Sep;1(3):187-203. Review.

PMID:
11428989
18.

Describing the silent human virome with an emphasis on giant viruses.

Popgeorgiev N, Temmam S, Raoult D, Desnues C.

Intervirology. 2013;56(6):395-412. doi: 10.1159/000354561. Epub 2013 Oct 17. Review.

19.

The human gut microbiota and virome: Potential therapeutic implications.

Scarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A, Gasbarrini A.

Dig Liver Dis. 2015 Dec;47(12):1007-12. doi: 10.1016/j.dld.2015.07.008. Epub 2015 Jul 18. Review.

20.

Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.

Paolillo JA, Boyle GJ, Law YM, Miller SA, Lawrence K, Wagner K, Pigula FA, Griffith BP, Webber SA.

Transplantation. 2001 Jan 27;71(2):252-6.

PMID:
11213069

Supplemental Content

Support Center